Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Merck & Company Inc (MRK)

NYSE
Symbol
Exchange
Currency
MRKNYSEUSD
0QAHLondonUSD
MRKMexicoMXN
1MRKXMilanEUR
MRKXetraEUR
MRKTradeGateEUR
MRKFrankfurtEUR
MRKBuenos AiresARS
MRCK34B3BRL
MRKViennaEUR
MRKUkraineUAH
MRKLimaUSD
Currency in USD
Disclaimer
125.31
+0.09(+0.07%)
Real-time Data

MRK Comments

Buffett's Berkshire exited Merck (MRK) as well as Merck spinoff Organon (OGN). It further slashed positions in AbbVie (ABBV) and Bristol-Myers Squibb (BMY),
MRK: Merck granted FDA approval for Keytruda as adjuvant therapy in renal cell carcinoma
good 🇵🇰 👍 🇵🇰 👍
y'all should do research before commenting. this company has a ton of different revenue streams. and is a value buy even if Covid pill wasn't created
Choosing not to get vaccinated would be a tragic mistake," said Albert Bourla, chief executive officer of Pfizer "These are treatments. This is for the unfortunate who will get sick," Bourla told Reuters in an interview on Friday. "This should not be a reason not to protect yourself and to put yourself, your household and society in danger
ya but the vaccines do nothing to stop the spread. not to mention they also have a 20% injury rate compared to the 0.003% morality of the virus..
By relying exclusively on an antiviral drug, it's a bit of a roll of the dice in terms of how you will do. Clearly, it's going to be better than nothing, but it's a high-stakes game to play," said Dr. Peter Hotez, a vaccine expert and professor of molecular virology and microbiology at Baylor College of Medicine.
no soon back under 80 76$ we go no matter the fraud headlines uk accepted it and in a public opinion 97.8% of the voters on the sun article avout would u choose pill above injection voted no 3.11M votes placed. says enough
100
This has great upward potential...this will reach its ATH and keep heading up. Hodl
Japan to pay $1.2 billion for 1.6 million courses of Merck's COVID-19 pill
Fair value around $90
https://www.investing.com/news/stock-market-news/analysis--covid19-pills-are-coming-but-no-substitute-for-vaccines-disease-experts-say-2672084
is it a good buy at $81?
yes
Very good price
The reason matters as these are planned and pre-approved.
inside info?
The reason matters.
mrk CFO sold the company shares around 1MM on Thursday.
Its hreat company with product been approved. Oversold for this morning.
Great**
I have kept MRK since 1995 (@ $22) and been happy with it as a very long term hold.
this company makes almost 50 billion a year without the COVID pill.
are u sure you would like to take pills for prevention actions on time? or u prefer to have 2 shots?
or 4 shots.. or 5.. maybe 6.. fast forward 2030.. 10th booster shot
those shots have a 20% injury rate compared to 0.003% covid fatality rate. unless you are high right you'd have to be insane to inject that medical experiment...statistically speaking..
can some one explain whyyyyyy?
here is strong support
 but Pfizer wont go further up...it didnt go further up with its Covid vaccines...so I choose Merck...better potential
Why doesn't matterif you knew why, you would've got in before the market crowd and the consensus
TSL hit on 1500 Kold. Put proceeds in MRK.
Is it possible this will see 100 before year end?
In my opinion, its more possible for Merck to see $100+ than its for Pfizer to see $53. Pfizer stock is incredibly difficult to go up. I prefer Merck stock.
Seems oversold at this point
Pfizer pre market +12!
You see that is -10?
Pizer +10-+12, and Merck -10
...
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.